The implementation of the Agreement on Aspects of Intellectual Property Rights (TRIPS)

The implementation of the Agreement on Aspects of Intellectual Property Rights (TRIPS) has recently been the subject of another extension. Indeed, in a decision of 6 November 2015, the Council for TRIPS granted to the least developed countries, additional time to transpose its provisions on patents for pharmaceutical products. Consequently, least developed countries have the ability to import or manufacture locally, generic drugs, regardless of the rules on pharmaceutical patents until 1st January 2033. Such a decision is not unprecedented but it raises questions about the effectiveness of the agreement. (C) 2016 Elsevier Masson SAS. All rights reserved.